| pubmed-article:3003249 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3003249 | lifeskim:mentions | umls-concept:C0205145 | lld:lifeskim |
| pubmed-article:3003249 | lifeskim:mentions | umls-concept:C0052887 | lld:lifeskim |
| pubmed-article:3003249 | lifeskim:mentions | umls-concept:C0441472 | lld:lifeskim |
| pubmed-article:3003249 | lifeskim:mentions | umls-concept:C1704675 | lld:lifeskim |
| pubmed-article:3003249 | lifeskim:mentions | umls-concept:C0443199 | lld:lifeskim |
| pubmed-article:3003249 | lifeskim:mentions | umls-concept:C0332120 | lld:lifeskim |
| pubmed-article:3003249 | pubmed:issue | 3-4 | lld:pubmed |
| pubmed-article:3003249 | pubmed:dateCreated | 1986-3-26 | lld:pubmed |
| pubmed-article:3003249 | pubmed:abstractText | Treatment of mice with DSP4 (a neurotoxin that abolishes the presynaptic noradrenergic neuron; Dooley et al., 1983) resulted in: (A) a decrease in the Bmax for the low affinity GABA-B receptor site in the cerebral cortex and hippocampus, whereas the Bmax for the high affinity GABA-B receptor site was unaffected; (B) a greater potentiation of norepinephrine stimulated adenylate cyclase by baclofen in cerebral cortex slices; and (C) a decrease in the Bmax for both the high and low affinity GABA-A receptor sites in the cerebral cortex and hippocampus. These data, coupled with previous work from our laboratory, suggest that the GABA-B receptor may be associated with both the noradrenergic nerve terminal and the post-synaptic neuron receiving noradrenergic input, whereas the GABA-A receptor may be associated with the noradrenergic nerve terminal. These data further suggest a functional coupling between the noradrenergic and GABA-ergic systems. | lld:pubmed |
| pubmed-article:3003249 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3003249 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3003249 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3003249 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3003249 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3003249 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3003249 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3003249 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3003249 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3003249 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3003249 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3003249 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3003249 | pubmed:issn | 0300-9564 | lld:pubmed |
| pubmed-article:3003249 | pubmed:author | pubmed-author:GianutsosGG | lld:pubmed |
| pubmed-article:3003249 | pubmed:author | pubmed-author:SuzdakP DPD | lld:pubmed |
| pubmed-article:3003249 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3003249 | pubmed:volume | 64 | lld:pubmed |
| pubmed-article:3003249 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3003249 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3003249 | pubmed:pagination | 163-72 | lld:pubmed |
| pubmed-article:3003249 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:3003249 | pubmed:meshHeading | pubmed-meshheading:3003249-... | lld:pubmed |
| pubmed-article:3003249 | pubmed:meshHeading | pubmed-meshheading:3003249-... | lld:pubmed |
| pubmed-article:3003249 | pubmed:meshHeading | pubmed-meshheading:3003249-... | lld:pubmed |
| pubmed-article:3003249 | pubmed:meshHeading | pubmed-meshheading:3003249-... | lld:pubmed |
| pubmed-article:3003249 | pubmed:meshHeading | pubmed-meshheading:3003249-... | lld:pubmed |
| pubmed-article:3003249 | pubmed:meshHeading | pubmed-meshheading:3003249-... | lld:pubmed |
| pubmed-article:3003249 | pubmed:meshHeading | pubmed-meshheading:3003249-... | lld:pubmed |
| pubmed-article:3003249 | pubmed:meshHeading | pubmed-meshheading:3003249-... | lld:pubmed |
| pubmed-article:3003249 | pubmed:meshHeading | pubmed-meshheading:3003249-... | lld:pubmed |
| pubmed-article:3003249 | pubmed:meshHeading | pubmed-meshheading:3003249-... | lld:pubmed |
| pubmed-article:3003249 | pubmed:meshHeading | pubmed-meshheading:3003249-... | lld:pubmed |
| pubmed-article:3003249 | pubmed:meshHeading | pubmed-meshheading:3003249-... | lld:pubmed |
| pubmed-article:3003249 | pubmed:year | 1985 | lld:pubmed |
| pubmed-article:3003249 | pubmed:articleTitle | GABA-noradrenergic interaction: evidence for differential sites of action for GABA-A and GABA-B receptors. | lld:pubmed |
| pubmed-article:3003249 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3003249 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:3003249 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3003249 | lld:pubmed |
